Imagion AG, a privately owned German company founded in 2000, provides broadcast professional services, specializing in authoring and encoding for video-on-demand (VOD) content. Employing approximately 30 people, the company's most recent annual revenue (2023) was less than $10 million.
On an unspecified date, Imagion Biosystems' executive chairman, Robert Proulx, discussed the company’s cancer-detecting imaging agent technology with Stockhead’s Fraser Palamara. The discussion covered the technology's current state, challenges in cancer detection, and its potential to improve diagnosis. On an unspecified date, the company filed an application with the US Food and Drug Administration (FDA) for initiated manufacturing of its MagSense HER2 imaging agent. This step is necessary for filing an Investigational New Drug (IND) application with the FDA by mid-2025. A new batch of MagSense HER2, intended for a phase II study, began manufacturing on an unspecified date. This batch will support the proposed IND application. On an unspecified date, Imagion Biosystems announced a $3 million capital raise, with funds allocated to advancing the MagSense platform technology, aiming to revolutionize cancer diagnosis through molecular imaging in MRI. The company plans to initially focus on HER2+ breast cancer staging, with future applications for prostate and ovarian cancers. Finally, on an unspecified date, Imagion Biosystems appointed Melanie Leydin as a non-executive director. Ms. Leydin brings over 25 years of accounting experience and 15 years as a company secretary, with expertise in public company responsibilities.
Imagion offers 4 products in the media tech industry. Imagion's product portfolio comprises of broadcast professional services and content supply chain.
Subscribe for full access to Imagion's products in full detail
Imagion's revenues were less than $10M in 2023. Caretta Research has split Imagion's revenue into 4 different product categories, the largest of which is post production services. For full access to Imagion's revenue breakdown subscribe to Caretta Portal.
Subscribe for full access to Imagion's revenue in full detail
Subscribe for full access to Imagion's products in full detail 
